| ASSET | YEAR | % RETURN |
|---|---|---|
BioXcel Therapeutics (BTAI) | 2018 | -64.97% |
BioXcel Therapeutics (BTAI) | 2019 | 289.6% |
BioXcel Therapeutics (BTAI) | 2020 | 218.62% |
BioXcel Therapeutics (BTAI) | 2021 | -58.58% |
BioXcel Therapeutics (BTAI) | 2022 | 4.83% |
BioXcel Therapeutics (BTAI) | 2023 | -86.08% |
BioXcel Therapeutics (BTAI) | 2024 | -87.15% |
BioXcel Therapeutics (BTAI) | 2025 | -74.01% |
BioXcel Therapeutics (BTAI) | 2026 | 23.31% |
